Clinical efficacy of kava extract WS 1490 in sleep disturbances associated with anxiety disorders. Results of a multicenter, randomized, placebo-controlled, double-blind clinical trial By Guilherme GuainJune 30, 2022
The Kava Anxiety Depression Spectrum Study (KADSS): a randomized, placebo-controlled crossover trial using an aqueous extract of Piper methysticum By Guilherme GuainJune 30, 2022
Efficacy of kava-kava in the treatment of non-psychotic anxiety, following pretreatment with benzodiazepines By Guilherme GuainJune 30, 2022
Kava-kava extract WS 1490 versus placebo in anxiety disorders–a randomized placebo-controlled 25-week outpatient trial By Guilherme GuainJune 30, 2022
Inositol 6 g daily may be effective in depression but not in schizophrenia By Guilherme GuainJune 30, 2022
Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone By Guilherme GuainJune 30, 2022
